CBL0137, CAS [[1197996-80-7]]

Produktübersicht

• Artikelname: CBL0137, CAS [[1197996-80-7]]
• Artikelnummer: BYT-ORB1303131
• Hersteller Artikelnummer: orb1303131
• Alternativnummer: BYT-ORB1303131-1, BYT-ORB1303131-1, BYT-ORB1303131-10, BYT-ORB1303131-100, BYT-ORB1303131-25, BYT-ORB1303131-5, BYT-ORB1303131-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: NFkB, NF-kB, NFkappaB, NF-kappaB, p53, CBLC 137, CBL0137, CBL-0137, CBLC137, CBLC-137, CBL 0137, Curaxin 137

Produktbeschreibung

CBL0137 is a metabolically stable curaxin that potently activates p53 and inhibits NF-kappaB by inactivating the FACT complex. It demonstrates broad in vivo anticancer activity, eradicates resistant cancer stem cells, and synergizes with gemcitabine in preclinical pancreatic cancer models.

Produkteigenschaften

• Molekulargewicht: 336.43
• Reinheit: 99.68% (May vary between batches)
• CAS Nummer: [1197996-80-7]
• Formel: C21H24N2O2
• Target-Kategorie: NF-kappaB,Histone Acetyltransferase,p53,MDM-2/p53

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: H2O:Insoluble,10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.94 mM),DMSO:25 mg/mL (74.31 mM)